362 related articles for article (PubMed ID: 26470815)
1. Innate lymphoid cells in inflammatory bowel diseases.
Peters CP; Mjösberg JM; Bernink JH; Spits H
Immunol Lett; 2016 Apr; 172():124-31. PubMed ID: 26470815
[TBL] [Abstract][Full Text] [Related]
2. Innate and adaptive immunity in inflammatory bowel disease.
Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
[TBL] [Abstract][Full Text] [Related]
3. Innate Lymphoid Cells in Inflammatory Bowel Disease.
Li J; Glover SC
Arch Immunol Ther Exp (Warsz); 2018 Dec; 66(6):415-421. PubMed ID: 30155762
[TBL] [Abstract][Full Text] [Related]
4. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy in inflammatory bowel disease: Novel and emerging treatments.
Catalan-Serra I; Brenna Ø
Hum Vaccin Immunother; 2018; 14(11):2597-2611. PubMed ID: 29624476
[TBL] [Abstract][Full Text] [Related]
6. The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD.
Goldberg R; Prescott N; Lord GM; MacDonald TT; Powell N
Nat Rev Gastroenterol Hepatol; 2015 May; 12(5):271-83. PubMed ID: 25971811
[TBL] [Abstract][Full Text] [Related]
7. Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis.
Triggianese P; Conigliaro P; Chimenti MS; Biancone L; Monteleone G; Perricone R; Monteleone I
Clin Exp Rheumatol; 2016; 34(6):1085-1093. PubMed ID: 27782868
[TBL] [Abstract][Full Text] [Related]
8. The innate immune system and inflammatory bowel disease.
Davies JM; Abreu MT
Scand J Gastroenterol; 2015 Jan; 50(1):24-33. PubMed ID: 25523553
[TBL] [Abstract][Full Text] [Related]
9. Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease.
Kmieć Z; Cyman M; Ślebioda TJ
Adv Med Sci; 2017 Mar; 62(1):1-16. PubMed ID: 28126697
[TBL] [Abstract][Full Text] [Related]
10. ILC3 function as a double-edged sword in inflammatory bowel diseases.
Zeng B; Shi S; Ashworth G; Dong C; Liu J; Xing F
Cell Death Dis; 2019 Apr; 10(4):315. PubMed ID: 30962426
[TBL] [Abstract][Full Text] [Related]
11. Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium.
Creyns B; Jacobs I; Verstockt B; Cremer J; Ballet V; Vandecasteele R; Vanuytsel T; Ferrante M; Vermeire S; Van Assche G; Ceuppens JL; Breynaert C
Front Immunol; 2020; 11():1847. PubMed ID: 32983101
[TBL] [Abstract][Full Text] [Related]
12. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
[TBL] [Abstract][Full Text] [Related]
13. Innate lymphoid cell-derived cytokines in autoimmune diseases.
Li S; Yang D; Peng T; Wu Y; Tian Z; Ni B
J Autoimmun; 2017 Sep; 83():62-72. PubMed ID: 28479212
[TBL] [Abstract][Full Text] [Related]
14. Emerging biotherapies for inflammatory bowel disease.
Cuzzocrea S
Expert Opin Emerg Drugs; 2003 Nov; 8(2):339-47. PubMed ID: 14661993
[TBL] [Abstract][Full Text] [Related]
15. The Role of Immune and Epithelial Stem Cells in Inflammatory Bowel Disease Therapy.
Binienda A; Ziolkowska S; Hauge IH; Salaga M
Curr Drug Targets; 2020; 21(14):1405-1416. PubMed ID: 32364073
[TBL] [Abstract][Full Text] [Related]
16. Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?!
Pantazi E; Powell N
Front Immunol; 2019; 10():676. PubMed ID: 31024537
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of Group 3 Innate Lymphoid Cells in the Pathogenesis of Inflammatory Bowel Disease.
Forkel M; Mjösberg J
Curr Allergy Asthma Rep; 2016 Oct; 16(10):73. PubMed ID: 27645534
[TBL] [Abstract][Full Text] [Related]
18. An immunomodulation strategy targeted towards immunocompetent cells or cytokines in inflammatory bowel diseases (IBD).
Heresbach D; Sémana G; Gosselin M; Bretagne MG
Eur Cytokine Netw; 1999 Mar; 10(1):7-15. PubMed ID: 10210767
[TBL] [Abstract][Full Text] [Related]
19. Regulation of intestinal health and disease by innate lymphoid cells.
Sonnenberg GF
Int Immunol; 2014 Sep; 26(9):501-7. PubMed ID: 24821261
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases.
Defendenti C; Atzeni F; Malandrin S; Ardizzone S; Almasio PL; Saibeni S; Bezzio C; Bollani S; Salerno R; Declich P; Sarno Z; Bruno S; Talotta R; Sarzi-Puttini P
Int Immunopharmacol; 2018 Jan; 54():329-335. PubMed ID: 29197269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
